Home » Topics » BioWorld Science

BioWorld Science
RSS

ELU-001 shows efficacy and safety in preclinical models of FRalpha-overexpressing cancers

Dec. 17, 2021

Researchers discover novel genes tied to classical Hodgkin's lymphoma predisposition

Dec. 17, 2021

Janssen discloses DHODH inhibitors

Dec. 17, 2021

Proof of concept for novel NASH approach

Dec. 17, 2021

Eli Lilly and Company presents new NTRK1 inhibitors

Dec. 17, 2021

Pfizer synthesizes new JAK1 inhibitors

Dec. 17, 2021

Sanofi patents IL-17A/IL-17RA interaction inhibitors

Dec. 17, 2021

TAXIS Pharmaceuticals divulges bacterial efflux pump inhibitors

Dec. 17, 2021

Factor V/Va-targeting MAb GB-5 promotes thrombus formation in vivo for treating bleeding disorders

Dec. 17, 2021

Targeting S100A7/RAGE signaling pathway inhibits breast tumorigenesis

Dec. 17, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...